http://www.pharmaceutical-journal.com/news-and-analysis/notice-board/antiviral-medicines-for-influenza-should-not-be-prescribed/20068540.article
Posted by Rob Lambkin-Williams
hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
No comments:
Post a Comment